Evidence map›Paper›PMID 30616520›Full record

ArticleBMC cancer2019

Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.

Gui-Cen Liu, Yun-Fei Zhou, Xiao-Chao Su, Jun Zhang

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Association between theFrontiers in oncology · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Common Variants in One-Carbon Metabolism Genes (International journal of molecular sciences · 2023
    Article
  9. Article
  10. Review
  11. Association ofFrontiers in genetics · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gui-Cen LiuInstitute of Molecular Medicine and Oncology, Chongqing Medical University, Yuzhong District, Chongqing City, 400016, China.
Yun-Fei ZhouInstitute of Molecular Medicine and Oncology, Chongqing Medical University, Yuzhong District, Chongqing City, 400016, China.
Xiao-Chao SuInstitute of Molecular Medicine and Oncology, Chongqing Medical University, Yuzhong District, Chongqing City, 400016, China.
Jun ZhangInstitute of Molecular Medicine and Oncology, Chongqing Medical University, Yuzhong District, Chongqing City, 400016, China. zhangjun1017@sohu.com.ORCID http://orcid.org/0000-0002-9549-4773
Chongqing Medical University · CN

Funding

the National Natural Science Foundation of China 20803098
6 · The paper itself

Abstract

backgroundCervical cancer is the 4th highest cause of female reproductive tract malignancies. Multiple loci have been identified as important determinant factors for tumor susceptibility. In this report, we aimed to explore the roles of gene polymorphisms affecting x-ray repair cross complementing 1 (XRCC1), the tumor protein p53 (TP53), and fibroblast growth factor receptor 3 (FGFR3) in the context of susceptibility to cervical cancer. Additionally, we assessed the impact of single nucleotide polymorphism-single nucleotide polymorphism (SNP-SNP) interaction of these three genes in the context of cervical cancer risk in Chinese women.

methodsA case-control study consisted of 340 women located in Chongqing. Of these women, 121 were diagnosed with cervical cancer, 118 served as healthy controls, and 101 were specifically recruited elderly patients above the age of 80 who showed no history of cervical cancer. Three SNPs (XRCC1 rs25487, TP53 rs1042522, and FGFR3 rs121913483) were examined using mutation analysis of mismatch amplification PCR (MAMA-PCR) on samples obtained from peripheral blood.

resultsOur results indicated that females from southwestern China all exhibited a wild-type phenotype at FGFR3 rs121913483. We also observed that the rs25487 mutation was significantly increased within the cervical cancer population. A 2-locus SNP-SNP interaction pattern (rs25487 and rs1042522) was significantly associated with cervical cancer risk (cases vs. negative controls: OR = 4.63, 95% CI = 1.83-11.75; cases vs. elderly group: OR = 17.61, 95% CI = 4.34-71.50).

conclusionsThis is the first study to identify a novel interaction between the XRCC1 and TP53 genes that is highly associated with susceptibility to cervical cancer risk in a female population in southwestern China.

Indexed as

AdultAgedAged, 80 and overCase-Control StudiesChinaFemaleGenetic Predisposition to DiseaseHumansMiddle AgedPolymorphism, Single NucleotideTumor Suppressor Protein p53Uterine Cervical NeoplasmsX-ray Repair Cross Complementing Protein 1TP53 protein, humanTumor Suppressor Protein p53X-ray Repair Cross Complementing Protein 1XRCC1 protein, humanCervical cancerFGFR3SNP-SNP interactionTP53XRCC1

Identifiers

PMID30616520
PMCPMC6323714
OpenAlexW2946855284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.